View all news

    Rybrevant PAPILLON Type II Extension of Indication Application Submitted to EMA

    10/06/2023
    Download(opens in new window)PDF

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com